Chugai Seiyaku Kabushiki Kaisha opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Chugai Seiyaku Kabushiki Kaisha

Patent Number:
Title:
Tgfbeta1-Binding Immunoglobulins And Use Thereof
Opposition Date:
Feb 16, 2024
Patent Number:
Title:
Compositions And Methods For Growth Factor Modulation
Opposition Date:
Jun 1, 2021
Patent Number:
Title:
Therapeutic And Diagnostic Target For Cancer Comprising Dll3 Binding Reagents
Opposition Date:
Feb 26, 2021

Latest patents of Chugai Seiyaku Kabushiki Kaisha opposed by its competitors

Patent:
Grant Date:
Jun 19, 2024
Title:
Multiple Antigen Binding Molecular Fusion, Pharmaceutical Composition, Method For Identifying Linear Epitope, And Method For Preparing Multiple Antigen Binding Molecular Fusion
Oppositions:
1
Patent:
Grant Date:
Nov 15, 2023
Title:
Fc Riib-Specific Fc Antibody
Oppositions:
1
Patent:
Grant Date:
Oct 11, 2023
Title:
Non-Human Animal Having Human Cd3 Gene Substituted For Endogenous Cd3 Gene
Oppositions:
1
Patent:
Grant Date:
Nov 2, 2022
Title:
Method For Measuring Reactivity Of Fviii
Oppositions:
2
Patent:
Grant Date:
Oct 26, 2022
Title:
Antitumor T Cell Response Enhancer
Oppositions:
1
Patent:
Grant Date:
Apr 6, 2022
Title:
Method For Purifying Composition Comprising Antibodies With Anionic Polymer
Oppositions:
1
Patent:
Grant Date:
Oct 13, 2021
Title:
Immunoactivating Antigen-Binding Molecule
Oppositions:
2
Patent:
Grant Date:
Sep 15, 2021
Title:
Methods For Controlling Blood Pharmacokinetics Of Antibodies
Oppositions:
2
Patent:
Grant Date:
Jun 23, 2021
Title:
Anti-Dll3 Antibody
Oppositions:
2
Patent:
Grant Date:
Mar 3, 2021
Title:
Stabilized Antibody-Containing Liquid Formulations
Oppositions:
5

Competitors of Chugai Seiyaku Kabushiki Kaisha

JAMES POOLE LIMITED

STRAWMAN LIMITED

GLAXO GROUP LIMITED

Want to track Chugai Seiyaku Kabushiki Kaisha?

Feel free to send us a message here and we will get back to you